The drug, gantenerumab, was abandoned by its developers, but subsequent anti-amyloid drugs lecanemab ( Leqembi) and donanemab ...

An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.That’s ...

Eli Lilly on Thursday expanded its direct-to-consumer online platform LillyDirect to include telehealth providers to diagnose ...

"They didn't value me as much," the actress says of initially not having the same name recognition as her male co-star The ...

Cassava Sciences said on Tuesday its Alzheimer's drug simufilam, which has been at the center of regulatory scrutiny, failed ...

In the first arrangement of its kind, Eli Lilly to connect patients through telemedicine to providers of Alzheimer’s drugs.

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...

An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.

Certain widely used drug combinations may either slow down or worsen the progression of Alzheimer's disease, but their ...

The biotechnology company Cassava Sciences failed on Wednesday to end a malicious prosecution lawsuit by doctors and ...

PathChat, a new AI model for pathology made by Modella AI, received breakthrough status in January. The device can digest ...